ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31

ANI PHARMACEUTICALS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$72.56+0.27 (+0.37%)

Close on Oct 19, 2026

Fundamental chart

Pick a measure to chart its full history

$883.37MFY2025, +72.3% a year since FY2011

Parsed from the XBRL in Ani Pharmaceuticals's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-6 reverse split on Jul 18, 2013
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ANIP.

Revenue growth30.9% · median 17.5%

Gross margin60.4% · median 83.5%

Operating margin15.4% · median -73.6%

Net margin11.1% · median -76.9%

Advertisement
300 × 250